Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jan 9, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc.
| -2.50K |
$48.79 | -$121,975.00 | -2.57% | 94.88K |
Jan 5
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| -2.50K |
$49.93 | -$124,825.00 | -2.50% | 97.38K |
Dec 1
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| -2.50K |
$60.83 | -$152,075.00 | -2.44% | 99.88K |
Nov 1
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| -2.50K |
$66.69 | -$166,725.00 | -2.38% | 102.38K |
Oct 3
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| -2.50K |
$60.30 | -$150,750.00 | -2.33% | 104.88K |
Sep 1
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| -2.50K |
$55.99 | -$139,975.00 | -2.28% | 107.38K |
Aug 1
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| -2.50K |
$41.78 | -$104,450.00 | -2.23% | 109.56K |
Jun 1
| |||||||
Apellis Pharmaceuticals, Inc.
| -4.38K |
$43.56 | -$108,900.00 | -3.76% | 112.06K |
Apr 21 - May 2
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.63K |
$21.94 | $15,331.25 | +6.03% | 116.44K |
Mar 15
| |||||||
Apellis Pharmaceuticals, Inc.
| -375.00 |
$43.53 | -$16,323.75 | -0.34% | 109.81K |
Mar 1
| |||||||
Apellis Pharmaceuticals, Inc.
| 4.1K |
$4.31 | $17,671.00 | +3.86% | 110.19K |
Feb 23
| |||||||
Apellis Pharmaceuticals, Inc.
| -375.00 |
$45.43 | -$17,036.25 | -0.35% | 106.09K |
Feb 15
| |||||||
Apellis Pharmaceuticals, Inc.
| 3.6K |
$4.31 | $15,516.00 | +3.50% | 106.46K |
Feb 14
| |||||||
Apellis Pharmaceuticals, Inc.
| -705.00 |
$47.12 | -$33,219.60 | -0.68% | 102.86K |
Feb 10
| |||||||
Apellis Pharmaceuticals, Inc.
| -375.00 |
$40.58 | -$15,217.50 | -0.36% | 103.57K |
Feb 1
| |||||||
Apellis Pharmaceuticals, Inc.
| -650.00 |
$38.59 | -$25,083.50 | -0.62% | 103.94K |
Jan 28
| |||||||
Apellis Pharmaceuticals, Inc.
| 26.05K |
—
|
—
| +33.17% | 104.59K |
Jan 21
| |||||||
Apellis Pharmaceuticals, Inc.
| 3.02K |
$22.44 | -$556.00 | +4.01% | 78.54K |
Jan 14
| |||||||
Apellis Pharmaceuticals, Inc.
| 5.16K |
$3.92 | $20,230.36 | +7.34% | 75.52K |
Jan 12
| |||||||
Apellis Pharmaceuticals, Inc.
| -375.00 |
$47.31 | -$17,741.25 | -0.53% | 70.35K |
Jan 3
| |||||||
Apellis Pharmaceuticals, Inc.
| -375.00 |
$42.88 | -$16,080.00 | -0.53% | 70.73K |
Dec 15
| |||||||
Apellis Pharmaceuticals, Inc.
| 7K |
$3.76 | $26,320.00 | +10.92% | 71.1K |
Dec 8
| |||||||
Apellis Pharmaceuticals, Inc.
| -375.00 |
$42.40 | -$15,900.00 | -0.58% | 64.1K |
Dec 1
| |||||||
Apellis Pharmaceuticals, Inc.
| -625.00 |
$43.50 | -$27,187.50 | -0.96% | 64.48K |
Nov 15
| |||||||
Apellis Pharmaceuticals, Inc.
| -625.00 |
$30.70 | -$19,187.50 | -0.96% | 64.81K |
Nov 1
| |||||||
Apellis Pharmaceuticals, Inc.
| -750.00 |
$34.57 | -$25,927.50 | -1.13% | 65.43K |
Oct 14
| |||||||
Apellis Pharmaceuticals, Inc.
| -750.00 |
$33.26 | -$24,945.00 | -1.12% | 66.18K |
Oct 1
| |||||||
Apellis Pharmaceuticals, Inc.
| 4K |
$3.76 | $15,040.00 | +6.36% | 66.93K |
Sep 28
| |||||||
Apellis Pharmaceuticals, Inc.
| -250.00 |
$63.99 | -$15,997.50 | -0.40% | 62.93K |
Aug 2
| |||||||
Apellis Pharmaceuticals, Inc.
| -500.00 |
$64.68 | -$32,340.00 | -0.79% | 63.18K |
Jul 14
| |||||||
Apellis Pharmaceuticals, Inc.
| -250.00 |
$65.68 | -$16,420.00 | -0.39% | 63.68K |
Jul 8
| |||||||
Apellis Pharmaceuticals, Inc.
| 9K |
$3.76 | $33,840.00 | +16.38% | 63.93K |
Jun 28
| |||||||
Apellis Pharmaceuticals, Inc.
| -500.00 |
$61.84 | -$30,920.00 | -0.90% | 54.93K |
Jun 14
| |||||||
Apellis Pharmaceuticals, Inc.
| -500.00 |
$45.39 | -$22,695.00 | -0.89% | 55.43K |
May 14
| |||||||
Apellis Pharmaceuticals, Inc.
| -600.00 |
$50.73 | -$30,438.00 | -1.07% | 55.61K |
May 3
| |||||||
Apellis Pharmaceuticals, Inc.
| -500.00 |
$42.82 | -$21,410.00 | -0.88% | 56.21K |
Apr 14
| |||||||
Apellis Pharmaceuticals, Inc.
| -600.00 |
$43.41 | -$26,046.00 | -1.05% | 56.71K |
Apr 1
| |||||||
Apellis Pharmaceuticals, Inc.
| -500.00 |
$46.77 | -$23,385.00 | -0.86% | 57.31K |
Mar 15
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
$25.91 | -$227,075.00 |
—
| 57.81K |
Mar 5
| |||||||
Apellis Pharmaceuticals, Inc.
| -600.00 |
$48.58 | -$29,148.00 | -1.03% | 57.81K |
Mar 1
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.